miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
about
The diagnostic effect of serum miR-196b as biomarker in colorectal cancerEpigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.DNA methylation of miRNA-encoding genes in non-small cell lung cancer patients.
P2860
miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
@en
type
label
miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
@en
prefLabel
miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
@en
P2093
P2860
P1433
P1476
miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
@en
P2093
Avrum Spira
Carmen S Tellez
Daniel E Juri
Maria A Picchi
Steven A Belinsky
Teresa Wang
P2860
P304
P356
10.1158/0008-5472.CAN-15-3367
P407
P577
2016-06-14T00:00:00Z